Skip to content

Diffuse Unilateral Subacute Neuroretinitis C0339404

Published: July 22, 2026Updated: August 27, 2026

A rare inflammatory eye disease caused by parasites affecting the retina and optic nerve. Early treatment with antiparasitic and anti-inflammatory medications can prevent vision loss. Prompt diagnosis is important for preserving sight.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Unilateral vision loss

!

Visual field defect

!

Optic disc edema

!

Retinal pallor

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antiparasitic medication therapy

Oral anthelmintic medications to eliminate the nematode parasite causing the infection. Treatment aims to halt progression and preserve remaining vision in affected eyes.

medication
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Laser photocoagulation

Direct laser ablation of visible subretinal worms when identifiable. This localized destruction targets the parasite while preserving surrounding retinal tissue.

procedure

Additional treatment options

Anti-inflammatory therapy

Corticosteroid therapy to manage the inflammatory response associated with dying parasites and to reduce secondary damage to retinal structures.

medication

Vitrectomy with parasite removal

Surgical intervention to remove the vitreous and potentially extract visible worms. Considered when medical therapy fails or parasites are surgically accessible.

surgical

Ophthalmologic surveillance

Long-term eye examinations including visual field testing, electroretinography, and imaging to monitor for disease progression, complications, and treatment response.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Diffuse Unilateral Subacute Neuroretinitis C0339404?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Diffuse Unilateral Subacute Neuroretinitis C0339404. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy